Bivigam 5 GM per 50 ML Injection
- RxCUI
- 1809416
- RxNorm name
- Bivigam 5 GM per 50 ML Injection
- Display name
- Bivigam 5 GM per 50 ML Injection
- Full name
- Bivigam 5 GM per 50 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125389 | Bivigam | Immune Globulin Intravenous (Human) | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a2244aa0-a6d0-11df-b385-0002a5d5c51b | Bivigam 10 % in 50 ML Injection [PSN] · 50 ML immunoglobulin G, human 100 MG/ML Injection [Bivigam] [SBD] · 50 ML Bivigam 100 MG/ML Injection [SY] · Bivigam 10 % per 50 ML Injection [SY] · Bivigam 5 GM per 50 ML Injection [SY] | 5 | 15 | These highlights do not include all the information needed to use BIVIGAM ® safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20250505 |
| 00dd9bbb-ee8b-f369-8cd1-6ce28925f118 | Bivigam 10 % in 50 ML Injection [PSN] · 50 ML immunoglobulin G, human 100 MG/ML Injection [Bivigam] [SBD] · 50 ML Bivigam 100 MG/ML Injection [SY] · Bivigam 10 % per 50 ML Injection [SY] · Bivigam 5 GM per 50 ML Injection [SY] | 5 | 2 | These highlights do not include all the information needed to use BIVIGAM safely and effectively. See full prescribing information for BIVIGAM. Immune Globulin Intravenous (Human), 10% Liquid BIVIGAM Initial U.S. Approval : 2012 | 20160225 |